Neurogene inc NGNE.US Value Analysis

US StockHealth Care
(No presentation for NGNE)

NGNE Value Score

3

24

15

Poor Growth
  • AI analysis rates NGNE  with the lowest value score of 1.
  • It is mainly due to  unstable operating cash flow, along with potential value may be lower.
  • Over the past 3 months, NGNE has maintained a consecutive value rating of 1.0, slightly lower than the rating of 1.5 over the past 3 years, indicating slight decrease in enterprise value.
  • Compared to all stocks in the Health Care sector, NGNE has a lower value rating.

NGNE Value Reference Factors

The Value score is derived from various data and factor information, integrated through AI algorithms. The following factors are part of the evaluation used by AI value scores.

No related data records

Update to 2025/03/27 (Weekly Update)

NGNE Financial Forecast

Unit : USD

Update to 2025/5/9 (Quarterly Update)

NGNE Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
-0.99
34.4%
12.4%
0
---
2024Q3
-1.19
76.8%
2.6%
0
---
2024Q2
-1.09
77.3%
-3.8%
0
--
-1,999.1%
2024Q1
-1
79.2%
11.9%
0
---
2023Q4
-1.51
73%
-28.7%
0
---

Update to 2025/5/10 (Quarterly Update)

NGNE Historical Value Score

You can use historical scores of 3 or above to observe potential performance and make investment decisions.

NGNE Value Strategy Backtest

The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.

Entry
Exit

The Backtest Result of NGNE from 2014/03 till Now

-
Cumulative Return
-
Annual Return
-
Volatility
-
Sharpe Ratio

Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from March, 2014 to May, 2025. (Total Trades: 0)

NGNESectorUS Overall Market
Wining Rate-45%54%
Avg Return-62.9%72.8%
Avg Profit-197.1%165.9%
Avg Loss--45.1%-34.6%
Avg Risk-Reward Ratio-437%479.2%

Update to 2025/5/10 (Daily Update)

Top 10 High Relevance to NGNE Value Score